The WHO has published the COVID-19 vaccines: safety surveillance manual to guide the processes for collecting, analysing and sharing safety data and information on COVID-19 vaccines within and across countries. To accompany this manual and facilitate the conduct of active safety surveillance studies using harmonized tools and methods, a protocol template for cohort event monitoring (CEM) studies has been developed. Read more about development of the protocol template, the cohort event monitoring (CEM) study design, and how it can identify previously unrecognised and unsuspected adverse reactions to the vaccine. The CEM protocol was commissioned by World Health Organization (WHO), coordinated by Dr. Christine Guillard with the support of Dr. Noha Iessa, in the Pharmacovigilance (PVG) team, within the Regulation and Prequalification department at WHO Headquarters.
- Hong Kong partners publish outcomes from carditis and COVID-19 vaccination association study January 26, 2022
- NZ hosts vaccine safety project January 25, 2022
- Dr Helen Petousis-Harris, finalist for the 2021 Nature Research Award for Driving Global Impact September 16, 2021
- The ACCESS Background rates report, excel sheets and event definitions are now available! August 28, 2021
- Funding for the Global Covid Vaccine Safety (GCoVS) project July 27, 2021